SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-096668
Filing Date
2024-08-14
Accepted
2024-08-14 08:04:13
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K achl-20240630.htm   iXBRL 6-K 110194
2 EX-99.1 achl-ex99_1.htm EX-99.1 177569
3 EX-99.2 achl-ex99_2.htm   iXBRL EX-99.2 1038381
4 EX-99.3 achl-ex99_3.htm EX-99.3 306554
5 GRAPHIC img60901631_0.jpg GRAPHIC 109156
  Complete submission text file 0000950170-24-096668.txt   6501553

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achl-20240630.xsd EX-101.SCH 954464
72 EXTRACTED XBRL INSTANCE DOCUMENT achl-20240630_htm.xml XML 1017562
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 241204267
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)